PCM Encore’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RXRX
PCM Encore's RXRX Position: Q3 2026 in Review
PCM Encore opened a new position in Recursion Pharmaceuticals (RXRX) in Q3 2026: 23,829 shares worth $98.4K. The stake represents 0.02% of the portfolio and ranks #445 among its holdings.
354 funds tracked by Wall St. Rank hold RXRX as of Q3 2026.
- PCM Encore held 23,829 shares of Recursion Pharmaceuticals worth $98.4K as of Q3 2026.
- Recursion Pharmaceuticals was a new PCM Encore position in Q3 2026.
- Recursion Pharmaceuticals made up 0.02% of PCM Encore's portfolio in Q3 2026, its #445 holding.
- 354 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2026.
Based on PCM Encore's 13F filing for Q3 2026, filed 19 Nov 2026.